217 related articles for article (PubMed ID: 17097722)
1. Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias.
Lai HC; Lin YW; Chang CC; Wang HC; Chu TW; Yu MH; Chu TY
Gynecol Oncol; 2007 Mar; 104(3):629-35. PubMed ID: 17097722
[TBL] [Abstract][Full Text] [Related]
2. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
[TBL] [Abstract][Full Text] [Related]
4. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.
Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D
Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C; Kweon SS; Fackler MJ; Sukumar S
Virchows Arch; 2010 Jul; 457(1):35-42. PubMed ID: 20496080
[TBL] [Abstract][Full Text] [Related]
6. Promoter methylation of SFRPs gene family in cervical cancer.
Chung MT; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Chu TY; Lai HC; Lin YW
Gynecol Oncol; 2009 Feb; 112(2):301-6. PubMed ID: 19038436
[TBL] [Abstract][Full Text] [Related]
7. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
[TBL] [Abstract][Full Text] [Related]
8. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
9. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
11. Physical and methylation status of human papillomavirus 16 in asymptomatic cervical infections changes with malignant transformation.
Dutta S; Chakraborty C; Dutta AK; Mandal RK; Roychoudhury S; Basu P; Panda CK
J Clin Pathol; 2015 Mar; 68(3):206-11. PubMed ID: 25563334
[TBL] [Abstract][Full Text] [Related]
12. TIMP-2 gene methylation in cervical precursor and invasive lesions.
Furtado Y; Almeida G; Silveira FA; Silva KS; Maldonado P; do Val IC; Cavalcanti S; L MA; Carvalho Mda G
Exp Mol Pathol; 2015 Feb; 98(1):119-23. PubMed ID: 25579181
[TBL] [Abstract][Full Text] [Related]
13. Distribution of human papillomavirus genotypes in archival cervical lesions in eastern inner Mongolian autonomous region, China.
Wu EQ; Yu XH; Zha X; Zhang GN; Wang JH; Fan Y; Tang YY; Zhao ZX; Wu YG; Kong W
Int J Gynecol Cancer; 2009 Jul; 19(5):919-23. PubMed ID: 19574785
[TBL] [Abstract][Full Text] [Related]
14. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
Steenbergen RD; Kramer D; Braakhuis BJ; Stern PL; Verheijen RH; Meijer CJ; Snijders PJ
J Natl Cancer Inst; 2004 Feb; 96(4):294-305. PubMed ID: 14970278
[TBL] [Abstract][Full Text] [Related]
15. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas.
Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F
Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209
[TBL] [Abstract][Full Text] [Related]
16. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Basu PS; Mondal RK; Roy A; Roychoudhury S; Panda CK
Mol Carcinog; 2012 Sep; 51(9):723-33. PubMed ID: 21809394
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
[TBL] [Abstract][Full Text] [Related]
18. Association between RASSF1A Promoter Hypermethylation and Oncogenic HPV Infection Status in Invasive Cervical Cancer: a Meta-analysis.
Li JY; Huang T; Zhang C; Jiang DJ; Hong QX; Ji HH; Ye M; Duan SW
Asian Pac J Cancer Prev; 2015; 16(14):5749-54. PubMed ID: 26320446
[TBL] [Abstract][Full Text] [Related]
19. Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development.
Kaur G; Balasubramaniam SD; Lee YJ; Balakrishnan V; Oon CE
Asian Pac J Cancer Prev; 2019 Oct; 20(10):3043-3049. PubMed ID: 31653153
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis.
Gustafson KS; Furth EE; Heitjan DF; Fansler ZB; Clark DP
Cancer; 2004 Aug; 102(4):259-68. PubMed ID: 15368319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
